Xealth, a digital health platform based in Seattle, has recently announced raising $24 million in Series B funding led by Advocate Aurora Enterprises, a subdivision of Advocate Aurora Health.
According to credible sources, Banner Health, Memorial Hermann, Cone Health, Novant Health, Nebraska Medicine, ChristianaCare, and Stanford Health Care were the seven health systems that join the existing health system investors Atrium Health, MemorialCare Innovation Fund, Cleveland Clinic, Froedtert & MCW Health Network, Providence and UPMC.
With this latest funding, Xealth has now reached a valuation of $52.6 million. The company will leverage these new funds to double its staff.
It will also aid product innovation and further bolstering its intelligence engine to better support healthcare systems for determining which tools are the best for patients, allowing it to expand deployment across the United States.
Xealth's digital health platform, which is used by over 100,000 physicians, plays a vital role in integrating digital health into clinician workflow, vital for program success.
The platform, which is tightly connected with electronic health records (EHRs), allows healthcare practitioners to customize digital solution ordering with just one click, enhancing patient experience.
Xealth, which was spun out of Providence in 2017, has support from 14 health systems and complete integrations with the top EHR suppliers.
The Xealth platform replaces existing clinician workflow with centralized integration, prescription, monitoring, and governance for digital health technologies, exhibiting a 50-80% decrease in integration and deployment costs, as well as significant patient engagement with digital assets.
Mike McSherry, CEO and Co-Founder of Xealth, said digital health use is hastening and will soon be a significant driver of growth for hospital systems.
The support from leading health systems, including Advocate Aurora, as well as The Health Management Academy, validates Xealth's method to integrating digital well-being in ways that authorize both providers and patients.
This support will also elevate the firm's growth, taking its technology vision to the top level and forming a tailored care experience that extends the connection between patients and clinical care teams, said Mr. Mike.